Dror Mevorach

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

B cell Maturation Antigen Targeted Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus and Systemic Sclerosis.

B cell Maturation Antigen Targeted Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus and Systemic Sclerosis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 11, 2026

Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.

Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.

Journal: Haematologica

Published: November 04, 2025

Clinical use of inpatient FDG-PET/CT in internal medicine.

Clinical use of inpatient FDG-PET/CT in internal medicine.

Journal: The American journal of medicine

Published: July 01, 2025

CD59 drives diet-induced obesity and glucose intolerance, insulin resistance, and metabolic dysfunction-associated steatotic liver disease.

CD59 drives diet-induced obesity and glucose intolerance, insulin resistance, and metabolic dysfunction-associated steatotic liver disease.

Journal: npj metabolic health and disease

Published: October 19, 2024

Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats.

Safety of Repeated Administration of Xenogeneic Human Apoptotic State (Allocetra-OTS) in Sprague Dawley Rats.

Journal: Pharmaceutics

Published: February 28, 2024

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19).

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19).

Journal: Circulation

Published: January 16, 2024

Apoptotic Cell-Based Therapy for the Modification of the Inflammatory Response to Hemorrhagic Shock.

Apoptotic Cell-Based Therapy for the Modification of the Inflammatory Response to Hemorrhagic Shock.

Journal: Military medicine

Published: November 27, 2023

HLA binding-groove motifs are associated with myocarditis induction after Pfizer-BioNTech BNT162b2 vaccination.

HLA binding-groove motifs are associated with myocarditis induction after Pfizer-BioNTech BNT162b2 vaccination.

Journal: European journal of clinical investigation

Published: August 31, 2023

Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19.

Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19.

Journal: Frontiers in immunology

Published: June 19, 2023

Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system.

Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system.

Journal: Journal of neuroinflammation

Published: March 26, 2023

A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations.

A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations.

Journal: Frontiers in immunology

Published: October 08, 2022

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination.

Journal: The New England journal of medicine

Published: September 21, 2022

Showing 1-12 of 58

Last Updated: 09/26/2026